This protocol is judged by an institutional evaluate board, an unbiased team that opinions any clinical trials involving human beings. If a review requires a Program I drug, once the board approves the protocol as ethical, the scientists need to submit an application for an investigational new drug (IND) number within the FDA.The effect sets in swi